Abstract
Kaposi sarcoma (KS) is a neoplasm of the endothelial cells. It often manifests with multiple vascular nodules on the skin and other organs. It is a systemic, malignant and multifactor disease and has a variable course. We describe an elderly Chinese man who had a rapidly growing maroon nodule on his right foot, both arms and cheekbones. KS in HIV-negative patients has only been reported sporadically.
Keywords: Kaposi sarcoma, disseminated, classic, HIV-negative, nodule
Introduction
Kaposi’s sarcoma is a frequent skin cancer in HIV-positive patients, but is relatively uncommon in HIV-negative and non-immune compromised patients. Kaposi’s sarcoma is the malignant proliferation of the endothelial cell vessels. Its genesis is still unclear; however, it seems to be related to the herpes virus infection (HHV-8). This neoplasia usually affects the lower limbs and the affected persons are mostly from the Mediterranean region. We present a case of disseminated Kaposi’s sarcoma in a HIV-negative male.
Case report
A 77-year-old man from China was admitted to our clinic with maroon nodule on his right lower extremities, dorsum of feet. Similar lesions were also present on the extremities and cheek. These lesions have been existed for two months. In the course of disease he had a fever for ten days. He appeared under gastrointestinal bleeding, left pleural effusion six months ago and was referred to our clinic with a prediagnosis of herpes zoster and sarcoidosis two months ago. He had quitted alcohol and cigarette smoking ten years ago. The patient denied homosexual activity. Physical examination showed no abnormalities. Lymphadenopathy was not detected. Dermatological examination revealed several purplish-brown nodules and plaques lesions sized 6 × 5 cm on the right dorsum of foot and lower extremities, similar lesions were present on the both arms and cheek as well (Figure 1A-D). Hemogram and biochemical tests were unremarkable except for mildly high total white blood cells of blood routine test. Serologic tests for RPR, TPPA and HIV were negative. Cd4+ cells were 16.9% (range: 27.4-42.1%), Cd8+ cells were 38.6% (range: 22.3-34.0%), and Cd4+/Cd8+ ratio was 0.44 (range: 1.02-1.95). Natural killer cells (NK) were 28.3% (range: 8.1~23.7%) HbsAg, HbeAb and HbcAb were positive. Multiple nodular, patchy high density shadow was in thorax CT (Figure 1). Complete work-up (including abdominal and lymph node ultrasound examinations) disclosed no signs of visceral involvement of his KS. Biopsies and immunohistochemical stains from one nodule and hyperkeratotic lesion were assessed as KS. Immunoperoxidase staining for CD34, CD31, SMA, P53 and Ki-67 were positive (Figure 1F-I). Cryotherapy for papulonodular lesions and local excision for hyperkeratotic lesion were performed and follow up was planned. But the patient refused to continue treatment.
Figure 1.

Multiple nodular, patchy high density shadow in thorax CT. A. Purplish-brown hyperkeratotic plaque and nodule on the dorsum of feet; B-D. Purplish-brown nodules on the cheek, right lower extremities, dorsum of hands and heels; E. Multiple nodular, patchy high density shadow in thorax CT; F. Spindle endothelial cells with mild atypia forming slits (H, E, × 400); G-I. Immunohistochemical staining; G. CD31 endothelial cell cytoplasmic staining (× 400); H. CD34 endothelial cell cytoplasmic staining (× 400); I. FVIII endothelial cell cytoplasmic staining (× 400).
Discussion
Kaposi’s sarcoma is a vascular neoplasm, described by Morris Kaposi in 1872. Kaposi’s sarcoma can be classified into four distinct forms: classic, endemic, iatrogenic and AIDS-associated [1,2]. When epidemiological features are considered, some races and certain age groups such as middle aged and elderly Meditarrenean or Jewish men and male gender are prone to have more KS and very rare in the rest of the world. However, KS patients with AIDS and African cases tend to be younger and the ratio of male/female is also reversed. Clinical presentation may be highly variable as well [3-5].
Classic KS is a spindle-shaped cell malignancy of endothelial cell origin that has a more benign and indolent course, and the affected organs are mainly skin, lower limbs and feet and rarely internal organs [6,7]. The primary presentation on the face and visceral involvement is rarely described in the HIV-negative and nonimmunosuppressed individual. But the differential diagnoses for facial lesion include pyogenic granuloma, histiocytoma, hemangioma and angiosarcoma [8]. Immunohistochemical staining may be done for CD34 antibody. It yields positive results for endothelial lining of slit like spaces and for spindle cells [2]. The pathogenesis of KS is uncertain. Current data support the notion that KS is a vascular hyperplasia with a tight link to HHV-8 infection. We described a disseminated presentation of classic Kaposi sarcoma in a HIV negative patient from China. This affected visceral involvement also. Disseminated KS found in the AIDS-associated and immunosuppression individual.
We describe a case of disseminated Kaposi sarcoma in HIV negative, face and visceral involvement Kaposi’s sarcoma are rare in immunocompetent individuals and but must be included in the differential diagnoses of suspicious facial lesions. Lesions are usually not associated with systemic involvement and can be treated with surgical excision. But the lesions of patient were extensive. And he refused the continual treatment and died after two months.
Acknowledgements
This work was funded by a grant from the ‘CMA-L’OREAL China Skin/Hair’ (S2013101026).
Disclosure of conflict of interest
None.
References
- 1.Mukai MM, Chaves T, Caldas L, Neto JF, Santamarίa JR. Primary Kaposi’s sarcoma of the penis. An Bras Dermatol. 2009;84:524–526. doi: 10.1590/s0365-05962009000500013. [DOI] [PubMed] [Google Scholar]
- 2.Borkovic SP, Schwartz RA. Kaposi’s sarcoma. Am Fam Physician. 1982;26:133–137. [PubMed] [Google Scholar]
- 3.Mohanna S, Maco V, Bravo F, Gotuzzo E. Epidemiology and clinical characteristics of classic Kaposi’s sarcoma, seroprevalance, and variants of human herpesvirus-8 in South America: a critical review of an old disease. Int J Infect Dis. 2005;9:239–250. doi: 10.1016/j.ijid.2005.02.004. [DOI] [PubMed] [Google Scholar]
- 4.Schwartz RA. Kaposi’s sarcoma: an update. J Surg Oncol. 2004;87:146–151. doi: 10.1002/jso.20090. [DOI] [PubMed] [Google Scholar]
- 5.Weissmann A, Linn S, Weltfriend S, Friedman-Birnbaum R. Epidemiological study of classic Kaposi’s sarcoma: a retrospective review of 125 cases from Northern Israel. J Eur Acad Dermatol Venereol. 2000;14:91–95. doi: 10.1046/j.1468-3083.2000.00022.x. [DOI] [PubMed] [Google Scholar]
- 6.Antman K, Chang Y. Kaposi’s sarcoma. N Engl J Med. 2000;342:1027–1038. doi: 10.1056/NEJM200004063421407. [DOI] [PubMed] [Google Scholar]
- 7.Schwartz RA, Micali G, Nasca MR, Scuderi L. Kaposi sarcoma a continuing conundrum. J Am Acad Dermatol. 2008;59:179–206. doi: 10.1016/j.jaad.2008.05.001. [DOI] [PubMed] [Google Scholar]
- 8.Wang X, Wang X, Liang D, Lan K, Guo W, Ren G. Classic Kaposi’s sarcoma in Han Chinese and useful tools for differential diagnosis. Oral Oncol. 2010;46:654–656. doi: 10.1016/j.oraloncology.2010.06.003. [DOI] [PubMed] [Google Scholar]
